[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624288":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":24,"centralContacts":29,"locations":10,"responsibleParty":38,"collaborators":10,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":67,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":10},{"fullName":5,"class":6},"Royal Marsden NHS Foundation Trust","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Semi-structured interview participants",null,"Up to 60 participants for semi-structured interviews, 20 from each of the following underserved groups in prostate cancer screening; Black African and Black Caribbean, transgender and non-binary with a prostate, reduced access to healthcare.",[13,14],"Other: Surveys","Other: Semi-structured interviews and focus groups",[16,20],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"Surveys","Up to 30 surveys with 10 of these individuals undergoing short interviews to assess the improvement of their understanding around prostate cancer",[9],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Semi-structured interviews and focus groups","Up to 60 total semi-structured interviews (up to 20 per underserved group) to assess barriers and facilitators to prostate cancer screening and how they would like information to improve their understanding to be presented.",[9],[25],{"name":26,"affiliation":27,"role":28},"Ros Eeles","Institute of Cancer Research, United Kingdom","STUDY_CHAIR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Rose Hall, MMBS","CONTACT","0000000000000000","rose.hall@icr.ac.uk",{"name":36,"role":32,"phone":10,"phoneExt":10,"email":37},"Elizabeth Bancroft","prostate.research@rmh.nhs.uk",{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100624288","improving-engagement-from-underserved-communities-with-prostate-cancer-genetics-services-100624288",false,"NCT07407686","Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services","Improving the Engagement of Underserved Communities With the Prostate Cancer Genetics Service: Identifying Barriers & Facilitators and Developing Supportive Resources Using a Co-production and Collaborative Approach","INCLUDE PC","Inclusion Criteria:\n\n1. Men and people with prostates age 18 and above\n2. Those who belong to the three underserved groups; Black African and Black Caribbean Ancestry, transgender and non-binary people with a prostate and those with reduced access to healthcare\n3. We allow intersectionality within reason and will narratively describe any instances of these in the writeup of findings\n4. Those who are able to freely consent to inclusion\n5. Individuals with and without a lived experience of prostate cancer\n\nExclusion Criteria:\n\n1. To avoid exhaustion, we will only allow participation in two interview or focus groups per individual for the entirety of the study\n2. Those without capacity to consent to interview (capacity is assumed unless there is good reason to believe otherwise)",true,"MALE","18 Years",{"count":52,"type":53},100,"ESTIMATED","OBSERVATIONAL","Earlier work explored barriers and facilitators to accessing prostate cancer screening, particularly in underserved communities, and provided valuable insights to build upon.\n\nThis study will explore perspectives on how genetic risk for prostate cancer is explained and understood through in-depth interviews with members of underserved communities. Findings from this work, alongside earlier results, will be used to co-design clear and accessible digital educational resources in collaboration with community members and relevant charities.\n\nParticipation in cancer screening programmes in the UK varies, with differences linked to socioeconomic status, ethnicity and health literacy. Similar inequalities are seen in access to prostate cancer genetics services, indicating a need for improved engagement.\n\nSuccessful integration of genetics into prostate cancer care requires clear and inclusive information about genetic testing processes, possible outcomes and interpretation of results. Currently, there are limited resources explaining genetic risk for prostate cancer in an accessible way.\n\nCo-production with representatives from underserved communities will ensure that educational materials are understandable, relevant and acceptable to all.",[57],"Prostate Cancer",[59,60,61,62,63,64,65,66],"qualitative research methods","co-production","MRC Complex Intervention Developement","Health Literacy and Health Behaviour Theories","Prostate cancer screening in high risk groups","semi-structured interviews and focus groups","reflexive thematic analysis of qualitative data","Evaluation of outputs","NOT_YET_RECRUITING","2026-02-05",{"date":70,"type":71},"2026-02-12","ACTUAL",{"date":73,"type":53},"2026-02-28",{"date":75,"type":53},"2027-12-31",{"name":5,"class":6}]